Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rinaldo

Showing results (261-270 of 324) with videos related to

Pageof 33
Sort By:
Plos Pathogens|June 26, 2007
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDSPing An, Li Hua Wang, Holli Hutcheson-Dilks, et al.
Nature Medicine|August 1, 1996
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaS J Gao, L Kingsley, M Li, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
AIDS (London, England)|September 6, 2013
CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppressionPatrick J Schuler, Bernard J C Macatangay, Zenichiro Saze, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2013
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapyBabafemi Taiwo, Roy M Matining, Lu Zheng, et al.
Journal of Immunological Methods|May 17, 2016
Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomersTricia L Gearhart, Ronald C Montelaro, Mark E Schurdak, et al.
Atherosclerosis|April 5, 2012
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort studyRulin C Hechter, Matthew Budoff, Howard N Hodis, et al.
The Journal of Infectious Diseases|December 10, 2015
Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic CellsBernard J C Macatangay, Sharon A Riddler, Nicole D Wheeler, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversionH Farzadegan, D R Henrard, C A Kleeberger, et al.
Journal of Virology|November 13, 1999
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infectionR Shankarappa, J B Margolick, S J Gange, et al.
Pageof 33

Showing results (261-270 of 324) with videos related to

Sort By:
Pageof 33
Plos Pathogens|June 26, 2007
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDSPing An, Li Hua Wang, Holli Hutcheson-Dilks, et al.
Nature Medicine|August 1, 1996
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaS J Gao, L Kingsley, M Li, et al.
AIDS Research and Human Retroviruses|March 11, 1990
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infectionL A Sawyer, D A Katzenstein, R M Hendry, et al.
AIDS (London, England)|September 6, 2013
CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppressionPatrick J Schuler, Bernard J C Macatangay, Zenichiro Saze, et al.
The Journal of Antimicrobial Chemotherapy|April 20, 2013
Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapyBabafemi Taiwo, Roy M Matining, Lu Zheng, et al.
Journal of Immunological Methods|May 17, 2016
Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomersTricia L Gearhart, Ronald C Montelaro, Mark E Schurdak, et al.
Atherosclerosis|April 5, 2012
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort studyRulin C Hechter, Matthew Budoff, Howard N Hodis, et al.
The Journal of Infectious Diseases|December 10, 2015
Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic CellsBernard J C Macatangay, Sharon A Riddler, Nicole D Wheeler, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversionH Farzadegan, D R Henrard, C A Kleeberger, et al.
Journal of Virology|November 13, 1999
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infectionR Shankarappa, J B Margolick, S J Gange, et al.
Pageof 33